Gide advised financial advisers SVB Securities, LifeSci Capital and Bryan and Garnier & Co. The banks were also advised by Cooley LLP on aspects of US...
Abivax’s EUR 130 Million Cross-Over Financing
Abivax’ €49.2 Million Financing
Foley & Lardner LLP represented TCG Crossover on the deal while Dechert advised Abivax. TCG Crossover (TCGX) acted as the lead investor in the successful, oversubscribed EUR...
Hashemite Kingdom of Jordan’s $650 Million Bond Offering
Dechert has advised the Hashemite Kingdom of Jordan, while Davis Polk advised the dealers on the deal. The Hashemite Kingdom of Jordan announced the establishment of...
Macro Group Pharmaceutical’s EGP1.3 Billion Initial Public Offering
Dechert advised EFG Hermes as sole global coordinator and EFG Hermes and Renaissance Capital as joint bookrunners on the IPO. Macro Group Pharmaceuticals (Macro Group), one...
Abivax’s €85 Million Funding Round
Dechert advised Abivax on the deal. Abivax, a Euronext Paris listed clinical-stage biotechnology company, executed its oversubscribed capital increase of €60 million and convertible bonds of...
Oman’s US$1.75 Billion Sukuk Offering
Dechert LLP has advised the Government of the Sultanate of Oman (acting through the Ministry of Finance) and Oman Sovereign Sukuk SAOC on the offering. Oman...